Home > Insider Trading > Filing (0000899243-21-034612)

Filing Details

Accession Number:: 0000899243-21-034612
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-08-31 18:04:37
Reporting Period:: 2021-08-25

Accepted Time:: 2021-08-31 18:04:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1800682	Cano Health Inc.	CANO	Services-Offices & Clinics Of Doctors Of Medicine (8011)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1865483	Marlow Hernandez	Cano Health, Inc. 9725 Nw 117Th Avenue, Suite 200 Miami FL 33178	Ceo And President	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Class A Common Stock	Acquisiton	2021-08-25	54,727	$11.93	311,627	No	4	P	Direct
Class A Common Stock	Acquisiton	2021-08-25	53,857	$11.94	53,857	No	4	P	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-26	14,560	$11.79	326,187	No	4	P	Direct
Class A Common Stock	Acquisiton	2021-08-26	6,240	$11.62	60,097	No	4	P	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-27	5,833	$11.84	332,020	No	4	P	Direct
Class A Common Stock	Acquisiton	2021-08-27	2,500	$11.77	62,597	No	4	P	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-30	5,833	$11.87	337,853	No	4	P	Direct
Class A Common Stock	Acquisiton	2021-08-30	2,500	$11.92	65,097	No	4	P	Indirect	See Footnote
Class A Common Stock	Acquisiton	2021-08-30	1,173,276	$10.75	1,511,129	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	See Footnote
No	4	P	Direct
No	4	P	Indirect	See Footnote
No	4	P	Direct
No	4	P	Indirect	See Footnote
No	4	P	Direct
No	4	P	Indirect	See Footnote
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Warrants to purchase Class A Common Stock	Acquisiton	2021-08-25	6,235	$3.62	6,235	$11.50
Class A Common Stock	Warrants to purchase Class A Common Stock	Acquisiton	2021-08-25	2,672	$3.62	2,672	$11.50
Class A Common Stock	Warrants to purchase Class A Common Stock	Acquisiton	2021-08-26	9,091	$3.81	9,091	$11.50
Class A Common Stock	Warrants to purchase Class A Common Stock	Acquisiton	2021-08-26	3,896	$3.81	3,896	$11.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
278,067	2021-07-03	2026-06-04	No	4	P	Direct
2,672	2021-07-03	2026-06-04	No	4	P	Indirect
287,158	2021-07-03	2026-06-04	No	4	P	Direct
6,568	2021-07-03	2026-06-04	No	4	P	Indirect

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.57 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(8) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.59 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(8) to this Form 4.
The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $11.52 to $12.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(8) to this Form 4.
The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $11.51 to $11.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(8) to this Form 4.
The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $11.66 to $11.95, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(8) to this Form 4.6
The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $11.62 to $11.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(8) to this Form 4.
The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $3.52 to $3.65, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(8) to this Form 4.
The price reported in Column 4 is a weighted average price. These warrants were purchased in multiple transactions at prices ranging from $3.55 to $3.85, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1)-(8) to this Form 4.
These shares are held indirectly by the reporting person through the Marlow B. Hernandez 2020 Family Trust.
These shares were purchased from an existing stockholder of the Issuer in a private transaction. The price per share was negotiated on an arm's-length basis and determined based on the opening price of Cano's Class A Common Stock on August 16, 2021.